AJOONI BIOTECH LIMITED
AJOONI · General/Diversified · NSE
₹4
Current Market Price
Fair Value (DCF)
₹3
Margin of Safety
-25.6%
Updated just now
YieldIQ Score
40/100
Piotroski F-Score
5/9
Economic Moat
None
Confidence
57%
ROE
5.5%
Debt/Equity
0.11
WACC
11.1%
Market Cap
₹73 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
5.1%
Return on capital employed
EV / EBITDA
11.2×
Enterprise multiple
Debt / EBITDA
0.3×
Leverage vs earnings
Interest Coverage
15.4×
EBIT covers interest
Current Ratio
12.86×
Short-term liquidity
Asset Turnover
1.21×
Revenue per ₹ of assets
Revenue CAGR (3Y)
15.7%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹4.26
Bear case
₹2.2
MoS -93.6%
Base case
₹3.17
MoS -34.4%
Bull case
₹4.41
MoS +3.4%
Ratio Trends
AJOONI · last 4 annual periods
ROE
3.8%
ROCE
6.4%
Operating Margin
—
Debt / Equity
0.02×
PE
60.5×
EV / EBITDA
23.9×
Historical Financials
AJOONI · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹51.0 Cr | ₹74.0 Cr | ₹74.5 Cr | ₹80.1 Cr | ₹115 Cr | +22.4% |
| EBITDA | — | ₹3.0 Cr | ₹3.1 Cr | ₹4.4 Cr | ₹5.7 Cr | +17.8% |
| EBIT | ₹1.1 Cr | ₹2.0 Cr | ₹2.1 Cr | ₹3.6 Cr | — | +34.4% |
| PAT | ₹0.4 Cr | ₹1.0 Cr | ₹1.1 Cr | ₹2.2 Cr | ₹3.4 Cr | +73.4% |
| EPS (diluted) | ₹0.37 | ₹1.05 | ₹1.94 | ₹0.25 | — | -9.3% |
| CFO | ₹1.2 Cr | ₹3.7 Cr | ₹-5.6 Cr | ₹-4.0 Cr | ₹-17.7 Cr | — |
| CapEx | — | — | — | — | ₹-2.0 Cr | — |
| FCF | — | — | — | — | ₹-19.8 Cr | — |
| Total Assets | — | ₹29.0 Cr | ₹5873.1K Cr | ₹47.5 Cr | ₹95.1 Cr | +34.5% |
| Total Debt | — | — | ₹343.0K Cr | ₹0.5 Cr | ₹1.9 Cr | -95.1% |
| Shareholders' Equity | — | — | ₹4166.9K Cr | ₹42.7 Cr | ₹88.1 Cr | -93.2% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
AJOONI vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| NGIL NGIL | — | — | Pending | -13.1% | — |
| ROML ROML | — | — | Pending | — | — |
| FCONSUMER FCONSUMER | — | — | Pending | 15.3% | — |
| KOHINOOR KOHINOOR FOODS LIMITED | +460.0% | 61 | Undervalued | — | — |
| PALASHSECU PALASH SECURITIES LTD | -100.0% | 32 | Data Limited | -2.1% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for AJOONI in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. AJOONI BIOTECH LIMITED (AJOONI.NS) trades at 4.26 vs a model fair value of 3.17, a gap of -25.6%. Piotroski F-score: 5/9. Moat label: Non...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of AJOONI →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for AJOONI →
Compare
Head-to-head with peers
Compare AJOONI side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse AJOONINow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.